Results 31 to 40 of about 114,880 (265)
Kidney & Blood Pressure Research, 2023 Background: Renal glycogen synthase kinase-3 beta (GSK3β) overactivity has been associated with a diverse range of kidney diseases. GSK3β activity in urinary exfoliated cells was reported to predict the progression of diabetic kidney disease (DKD).
Lingfeng Zeng +5 more
doaj +1 more source
Frontiers in Medicine, 2022 IntroductionUF insufficiency is a major limitation in PD efficiency and sustainability. Our study object to investigate the efficacy of intraperitoneal inflammation marker, IL-6 level as a predictor of UF insufficiency in continuous ambulatory peritoneal
Qianhui Song +19 more
doaj +1 more source
Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report
BMC Nephrology, 2018 Background Icodextrin is a starch-derived, water soluble glucose polymer, which is used as an alternative to glucose in order to enhance dialytic fluid removal in peritoneal dialysis patients.
Vassilios Liakopoulos +5 more
doaj +1 more source
Effect of frequent hemodialysis on residual kidney function. [PDF]
, 2013 Frequent hemodialysis can alter volume status, blood pressure, and the concentration of osmotically active solutes, each of which might affect residual kidney function (RKF).
Chertow, Glenn M +11 more
core +1 more source
Effect of high glucose concentration on the synthesis of monocyte chemoattractant protein-1 in human peritoneal mesothelial cells: Involvement of protein kinase C [PDF]
, 2001 Human peritoneal mesothelial cells (HMC) contribute to the activation and control of inflammatory processes in the peritoneum by their potential to produce various inflammatory mediators.
Haslinger, Bettina +4 more
core +1 more source
Peritoneal Dialysis–Associated Peritonitis [PDF]
Clinical Journal of the American Society of Nephrology, 2019 Peritonitis is a common and severe complication in peritoneal dialysis (PD). Detailed recommendations on the prevention and treatment of PD-associated peritonitis have been published by the International Society for Peritoneal Dialysis (ISPD), but there is a substantial variation in clinical practice among dialysis units.
Cheuk-Chun Szeto, Philip Kam-Tao Li
openaire +2 more sources
Calciphylaxis: A successful outcome whilst on peritoneal dialysis
Bulletin de la Dialyse à Domicile, 2019 Calciphylaxis is a life threatening disease for which patients with chronic kidney disease, particular those on dialysis, are at increased risk. As it is a rare condition, treatment options are limited and duration of treatment is not clear, especially ...
Ana Gaspar +5 more
doaj +1 more source
Incidence and outcome of encapsulating peritoneal sclerosis [PDF]
, 2016 Background: Studies report variation in the incidence and outcomes of encapsulating peritoneal sclerosis (EPS). This study reports the incidence and outcome of EPS cases in a national cohort of peritoneal dialysis (PD) patients.
Mactier, Robert A. +2 more
core +2 more sources
BMC Nephrology, 2018 Background Urinary mitochondrial DNA (mtDNA) fragment level has been proposed as a biomarker of chronic kidney disease (CKD). In this study, we determine the relation between urinary mtDNA level and rate of renal function deterioration in non-diabetic ...
Zhongping WEI +7 more
doaj +1 more source
Caveolin-1 deficiency induces a MEK-ERK1/2-Snail-1-dependent epithelial-mesenchymal transition and fibrosis during peritoneal dialysis [PDF]
, 2015 Peritoneal dialysis (PD) is a form of renal replacement therapy whose repeated use can alter dialytic function through induction of epithelial-mesenchymal transition (EMT) and fibrosis, eventually leading to PD discontinuation. The peritoneum from Cav1-/-
Enrique, Calvo +13 more
core +1 more source